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Abstract: Latent infection with the apicomplexan Toxoplasma gondii (Nicolle et Manceaux, 1908) has been associated with schizophrenia, bipolar disorder and self-harm behaviour. However, the potential relationship between T. gondii immunoglobulin G antibody (IgG) seropositivity and generalised-anxiety disorder (GAD) and panic disorder (PD) has not been investigated. The associations between serum reactivity to T. gondii and major depressive disorder (MDD), GAD and PD were evaluated in a total sample
of 1 846 adult participants between the ages of 20 and 39 years from the United States Center for Disease Control’s National Health
and Nutrition Examination Survey (NHANES). Approximately 16% of the overall sample was seropositive for T. gondii and 7% of
the sample met criteria for MDD, 2% for GAD and 2% for PD. There were no significant associations between T. gondii IgG seroprevalence and MDD (OR = 0.484, 95% CI = 0.186–1.258), GAD (OR = 0.737, 95% CI = 0.218–2.490) or PD (OR = 0.683, 95%
CI = 0.206–2.270) controlling for sex, ethnicity, poverty-to-income ratio and educational attainment. However, limited evidence
suggested a possible association between absolute antibody titres for T. gondii and GAD and PD but not MDD. Toxoplasma gondii
seroprevalence was not associated with MDD, GAD or PD within the context of the limitations of this study, although there may be
an association of T. gondii serointensity with and GAD and PD, which requires further study.
Keywords: Toxoplasma gondii, behaviour, mood, psychiatric, National Health and Nutrition Examination Survey (NHANES)

Toxoplasma gondii (Nicolle et Manceaux, 1908) is an
intracellular apicomplexan parasite (Berenreiterová et al.
2011) that can infect humans via congenital transmission
or ingestion of either tissue cysts from undercooked meat
or oocysts from cat faeces (Carruthers and Suzuki 2007).
Ingestion of raw oysters, clams and mussels or other raw
or undercooked meats such as pork and lamb has also
been linked with human T. gondii infection (Jones et al.
2009). Felines, including domestic cats, are the definitive
host of T. gondii, but humans and a variety of other vertebrates including rodents are intermediate hosts. In intermediate hosts following acute infection, T. gondii can
enter a latent phase, in which cysts form in neurons, microglia and astrocytes and in muscles, where they appear
to persist for the life of the host (Dubey 1998, Carruthers
and Suzuki 2007, Berenreiterová et al. 2011).
The prevalence of seropositivity for immunoglobulin
G antibodies (IgG) against T. gondii varies by age, ethnic
group and region (Jones et al. 2003). The overall worldwide prevalence of IgG seropositivity for T. gondii is approximately 30% (Montoya and Liesenfeld 2004, Henriquez et al. 2009).
In an immunocompetent host, latent infection with
T. gondii had been considered to be asymptomatic (Car-

ruthers and Suzuki 2007). However, based on the affinity of T. gondii for the brain, there has been interest in
how latent toxoplasmosis diagnosed by IgG antibodies
against T. gondii may affect brain function and behaviour.
In animal models, latent toxoplasmosis has been associated with decreased learning and memory and increased
activity (Xiao et al. 2012). Latent toxoplasmosis infection in rodents has been further associated with decreased
avoidance of a novel object or odour (Webster 2007),
and rodents with latent toxoplasmosis show a decreased
avoidance response to feline odours potentially related to
modification of the neural substrates underlying the anxiety and fear response (Vyas et al. 2007).
The decreased avoidance response may be sex-specific
and many of the alterations in genetic expression and behavioural changes associated with latent toxoplasmosis
appear to be sex-dependent in rodents (Xiao et al. 2012).
Xiao et al. (2012) found that female mice with latent toxoplasmosis were attracted to cat odour and had motor hyperactivity in an open-field test, whereas male mice with
latent toxoplasmosis showed deficits in socially transmitted food preference and odour perception. Berdoy et al.
(2000) suggested the decreased perception of risk might
be due to T. gondii acting as an anxiolytic-like agent. To-
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gether, these findings from animal models suggest that latent infection with toxoplasmosis may reduce an animal’s
avoidance to situations that normally would be avoided.
In humans, numerous behavioural changes are also associated with seropositivity for T. gondii. Latent infection
with toxoplasmosis is associated with differences in temperament, decreased novelty seeking (Novotná et al. 2005,
Skallová et al. 2005, Flegr 2013), and decreased conscientiousness. Flegr (2010) found that latent toxoplasmosis
infection is associated with the self-reported perception
of decreased diplomacy in both men and women. Flegr
(2010) also reported that women with latent toxoplasmosis infection were not anxious in situations in which
other people would be, a finding suggesting that latent
toxoplasmosis could be anxiolytic. There is also a strong
association between latent T. gondii infection and schizophrenia (Torrey et al. 2007, Fekadu et al. 2010) that may
involve Toxoplasma-induced changes in brain dopamine
(Flegr 2013). In addition to findings of psychiatric illness and differences in personality, a longitudinal study
by Pedersen et al. (2012) found that women with latent
toxoplasmosis had a higher risk of self-harm. The results
of a cross-sectional study indicated that T. gondii seropositivity was associated with nonfatal suicidal violence
(Zhang et al. 2012), findings that suggest seropositivity
for T. gondii may be associated with disinhibition. Despite the apparent association between latent toxoplasmosis and disinhibition, fear and novelty seeking in animal
models and human studies, few studies have examined
whether latent toxoplasmosis in humans is associated
with anxiety disorders such as panic disorder (PD) and
generalised anxiety disorder (GAD), and with mood disorders such as major depressive disorder (MDD) (Fekadu
et al. 2010). Two small studies involving primarily subjects with schizophrenia found no association between
latent infection with toxoplasmosis and MDD (Cetinkaya
et al. 2007, Hamidinejat et al. 2010), but another study,
while finding no difference in the prevalence of latent infection with T. gondii between a major-depression group
and controls, did find more people with high antibody titres against T. gondii in the group with depression than in
the control group (Hinze-Selch et al. 2007). Based on data
from the Third National Health and Nutrition Examination
Survey (NHANES), which collected data from 1988 to
1994, Pearce et al. (2012) found an association between
latent infection with T. gondii and bipolar I disorder but
no association with a history of major depression, severe
major depression, or major depression comorbid with dysthymia as diagnosed by the Diagnostic Interview Schedule (DIS) (Helzer and Robins 1988). In a case-control
study in a French sample, latent toxoplasmosis was associated with bipolar disorder (odds ratio 2.17, p = 0.028)
(Hamdani et al. 2013).
To our knowledge, no study to date has investigated
the association between latent infection with T. gondii
and either GAD or PD. To further clarify the association
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between unipolar mood disorders and latent toxoplasmosis and to investigate the relationship between latent
toxoplasmosis and GAD and PD, we used data from
the most recent continuous National Health and Nutrition Examination Surveys (NHANES) that contained the
relevant data to determine whether latent toxoplasmosis
identified by IGg antibody titre is associated with MDD,
PD or GAD in a large community sample weighted to be
representative of the United States population.
Materials and Methods
Study sample
We obtained cross-sectional data about MDD, GAD and
PD, Toxoplasma gondii IgG seropositivity, ethnic background,
sex, educational attainment, age and poverty-to-income ratio
in adults from the Center for Disease Control and Prevention’s
continuous NHANES datasets. This dataset uses complex, multi-stage sampling requiring weighting to represent the non-institutionalised United States population, and the NHANES survey
includes interviews, physical examinations and laboratory samples regarding participants’ medical and nutritional status (CDC
2014).
In the present study, we include only those adults over age
20 years for whom all testing data, including information about
the presence or absence of MDD, GAD and PD, anti-toxoplasmosis IgG antibody titres, and the relevant demographic and socioeconomic variables, were available. The NHANES dataset is
acquired in different cross-sectional samples in different years.
To increase the sample size and to take advantage of all the relevant NHANES data, we combined the 1999–2000, 2001–2002
and 2003–2004 NHANES datasets.
Because the NHANES survey collects different data points
during different years, and because we excluded participants
without all of the necessary data points, the final dataset only
included men and women between the ages of 20 and 39 years
of age. The combined data sets consisted of 31 126 participants,
of whom 1 846 had all of the variables necessary for our study
and were included in the analysis. In some analyses, somewhat
more subjects had all of the necessary variables for that particular analysis than another, and so the sample size in some
analyses varied.
The final sample size ranged up to 1 846, although this
number varied between analyses because of differences in the
numbers of subjects providing data relevant for the individual
analyses; 1 846 subjects had data for all of the variables used
in the analyses. Of these 1 846 subjects, the majority was NonHispanic White (50.43%). Fifty-five per cent of this sample was
female, and 49.19% had an education level greater than a highschool diploma (Table 1). The mean age for this study sample
was 29.7 ± 0.4 years, and the mean poverty income ratio (PIR)
was 2.31 ± 0.88 (Table 2).
Toxoplasma gondii IgG antibody
According to the NHANES lab methodology descriptions
(CDC 2014), the presence and quantity of IgG antibodies to
T. gondii were determined by enzyme-linked immunosorbent assay (ELISA). Using optical density readings from positive control sera wells, standard curves were constructed and readings
were calibrated to World Health Organization (WHO) Toxo 60
serum. We used the NHANES guidelines for each dataset to de-

Ahead of print online version
Gale et al.: Toxoplasmosis, depression and anxiety
Table 1. Frequency counts for the cross-classification of gender,
ethnicity and education.
Less than High school More than
high school diploma high school
Male
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – male
Female
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – female
Totals

Totals

Table 2. Mean ± standard deviation of ages and poverty-to-income ratio (PIR) for the cross-classification of gender, ethnicity
and education.
Less than High school More than
High school diploma high school

127
55
44
226

64
53
121
238

55
75
233
363

246
183
398
827

131
52
57
240

61
52
121
234

75
115
355
545

267
219
533
1 019

466

472

908

1 846

termine anti-Toxoplasma IgG concentrations indicative of latent
T. gondii infection and used a binary system to classify subjects
according to whether they had latent infection with T. gondii.
In this way, we were able to set specific conditions for each
individual data set, resulting in equivalent data across all three
data sets and consistent with the NHANES guidelines for determining anti-Toxoplasma IgG seropositivity. Because HinzeSelch et al. (2007) reported an association between serointensity
of anti-toxoplasmosis IgG and MDD, we also used absolute
anti-Toxoplasma IgG antibody levels in additional analyses to
determine the association between anti-Toxoplasma IgG antibody serointensity and MDD, PD, and GAD.
Mood and Anxiety Disorders
The NHANES survey used the World Health Organization’s
Composite International Diagnostic Interview (CIDI), a comprehensive structured interview to evaluate and diagnose mental
disorders present in the past 12 months. The CIDI is based on
diagnostic criteria according to the tenth revision of the International Classification of Diseases and the fourth edition of the
Diagnostic and Statistical Manual of Mental Disorders. Specifically, NHANES did not include the diagnostic modules for all
mental disorders addressed in the CIDI; rather, it utilised the
diagnostic modules for the diagnoses of MDD, PD and GAD.
Control variables
Demographic data were collected for all survey participants
through a household interview prior to the health examination.
The NHANES computer-assisted personal interview software
program was used to collect and record the interview data (CDC
2014). Since the prevalence of latent infection with T. gondii
can vary by age, ethnic group and region, we adjusted for the
following potentially confounding variables: gender, age, education (less than high school, high-school diploma, more than
high school), ethnicity (Mexican American, Non-Hispanic
white, Non-Hispanic black, and Other), and poverty income ratio (PIR), a measure of assessing household wealth (total family
income divided by the United States poverty threshold adjusted
for family size) with a value less than 1 indicative of an income
below the poverty threshold.
To produce unbiased national estimates, weights were created for each two-year data set. We obtained the weights used
in our study from the mood-disorder data sets in the examination portion of the NHANES since they were completely nested
within both the T. gondii and demographics data sets. A set of

Male – Age
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – male
Female – Age
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – female
Totals –Age
Male – PIR
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – male
Female – PIR
Mexican American
Non-Hispanic black
Non-Hispanic white
Total – female
Totals – PIR

Totals

29.2 ± 5.8
30.0 ± 6.1
30.3 ± 6.6
29.6 ± 6.0

29.6 ± 5.7
29.8 ± 6.1
30.3 ± 6.0
30.0 ± 5.9

30.0 ± 5.0 29.6 ± 5.5
29.4 ± 5.9 29.7 ± 6.0
30.1 ± 5.5 30.2 ± 6.0
29.9 ± 5.5 29.8 ± 5.8

28.3 ± 5.5
31.6 ± 6.2
28.7 ± 6.3
29.1 ± 6.0

28.9 ± 5.8
29.8 ± 6.4
29.4 ± 6.
29.4 ± 6.2

30.1 ± 5.9
30.0 ± 5.3
30.5 ± 5.2
30.3 ± 5.3

29.1 ± 5.7
30.5 ± 6.0
29.5 ± 5.9
29.6 ± 5.8

29.3 ± 6.1

29.7 ± 6.1

30.1 ± 5.5

29.7 ± 5.8

1.52 ± 1.01
1.60 ± 1.26
1.83 ± 1.23
1.69 ± 1.12

2.13 ± 1.25
2.31 ± 1.38
2.67 ± 1.48
2.44 ± 1.41

2.78 ± 1.50
2.71 ± 1.62
3.62 ± 1.55
3.30 ± 1.61

2.14 ± 1.25
2.21 ± 1.42
2.70 ± 1.42
2.45 ± 1.38

1.20 ± 0.81
1.11 ± 1.10
1.78 ± 1.57
1.32 ± 1.12

1.79 ± 1.30
1.61 ± 1.30
2.41 ± 1.45
2.07 ± 1.42

2.64 ± 1.63
2.40 ± 1.48
3.45 ± 1.51
3.12 ± 1.59

1.87 ± 1.25
1.71 ± 1.29
2.55 ± 1.51
2.17 ± 1.38

1.46 ± 1.15 2.26 ± 1.37 3.21 ± 1.56 2.31 ± 1.36

four-year weights had been created by the Center for Disease
Control for the 1999–2000 and 2001–2002 data sets. We used
the four-year weights for the first two data sets and a two-year
weight created for the 2003–2004 data set (CDC 2005, 2014).
In order to control for sampling-errors, stratum and primary
sampling units were used. These variables were included in, and
obtained from, the demographic data sets.
Statistical analyses
The three two-year data sets were appended by hand using
Microsoft Excel 2013, where we were also able to set specific
stipulations to our data such as the IgG-titre thresholds. Variables of interest were combined into one data set through the use
of the SAS MERGE function (SAS Institute, Cary, North Carolina). Logistic regression models were estimated in Stata 13.1
(Stata Corp. 2013). In our analyses, poverty-to-income ratio
(PIR) and age were quantitative, whereas latent Toxoplasma infection, depression and anxiety disorders (e.g. MDD, PD, GAD),
education, gender and ethnicity were all categorical variables.
We also estimated analyses with anti-toxoplasmosis IgG antibody level as a continuous variable separately for latent Toxoplasma-positive and negative groups. Analyses were performed
with and without covariates to assess possible confounding.

Results
Of the sample involving 1 846 participants, 15.8%
were seropositive for T. gondii IgG antibodies. There was
a slightly higher prevalence of infection in males (17.4%)
compared to females (13.6%), a difference that was not
statistically significant, (X2(1) = 2.378, p = 0.123). Toxoplasmosis seroprevalence differed by education level: less
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Table 3. Logistic regressions predicting major depressive disorder, panic disorder and generalised anxiety disorder from Toxoplasma
gondii IgG, gender, age, education level, poverty-to-income ratio (PIR) and ethnicity.
Major depressive disorder
Males
β
Toxoplasma positive
Malea
Toxoplasma X malea,b
Age
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Education
Poverty-to-income ratio
Constantc
N

-.720
.005

OR

Females

95% CI

p

.487 [.161,1.471] .196
1.005 [1.001,1.009] .026

.000 1.000 [1.000,1.000]
-1.189 .305
[.097,.959]
-.126 .882 [.400,1.945]
-.319 .727 [.387,1.363]
.058 1.060 [.869,1.293]
-3.627
[-5.569,-1.686]
824

.043
.750
.312
.556
-

Full sample

β

OR

95% CI

p

β

-.745
.003

.475
1.003

[.107,2.113]
[.998,1.007]

.320
.214

-.726
-.403
-.001
.003

.484 [.107,2.184]
.669 [.431,1.037]
.999 [.162,6.148]
1.003 [1.000,1.007]

.337
.071
.999
.033

.014
.038
.188
.085
-

.000 1.000 [1.000,1.000]
-1.118 .327
[.195,.547]
-.595 .551
[.327,.929]
-.269 .764 [.564,1.035]
-.098 .906 [.779,1.054]
-2.404
[-3.812,-.996]
1843

.000
.026
.081
.196
-

.000 1.000 [1.000,1.000]
-1.073 .342
[.147,.797]
-.922 .398
[.166,.950]
-.247 .781 [.539,1.133]
-.209 .811 [.638,1.031]
-1.900
[-3.607,-.193]
1019

OR

95% CI

p

Panic disorder (PD)
Males
Toxoplasma positive
Malea
Toxoplasma X malea,b
Age
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Education
Poverty-to-income ratio
Constantc
N
d

Females

Full sample

β

OR

95% CI

p

β

OR

95% CI

p

β

OR

95% CI

p

-.003

.997

[.987,1.007]

.570

.240
.004

1.271
1.004

[.366,4.409]
[.998,1.010]

.700
.156

-.381
-.476
.002

.683
.622
1.002

[.199,2.343]
[.294,1.313]
[.997,1.007]

.537
.207
.472

.000 1.000 [1.000,1.000]
-.382 .682 [.157,2.957]
-.632 .531 [.059,4.785]
-.274 .760 [.318,1.816]
-.242 .785 [.562,1.097]
-1.546
[-6.282,3.190]
684

.602
.565
.529
.151
-

.000 1.000 [1.000,1.000]
-2.500 .082
[.032,.210] .000
-1.059 .347
[.134,.896] .030
-.421 .657 [.398,1.083] .098
-.712 .490
[.355,.678] .000
-2.378
[-4.934,.178]
1019

.000 1.000 [1.000,1.000]
-1.467 .231
[.082,.646] .006
-.855 .425 [.174,1.039] .060
-.382 .682 [.453,1.028] .067
-.519 .595
[.448,.791] .001
-1.877
[-4.317,.563]
1846

Generalised anxiety disorder (GAD)
Males
Toxoplasma positive
Malea
Toxoplasma X malea,b
Age
Race-ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Education
Poverty-to-income ratio
Constantc
N
d

Females

Full sample

β

OR

95% CI

p

β

OR

95% CI

p

β

.006

1.006

[.993,1.019]

.374

.402
.006

1.494
1.006

[.437,5.113]
[.999,1.012]

.514
.074

-.306
-.368
.006

.000
.373
.123
.001
-

.000 1.000 [1.000,1.000]
-1.323 .266
[.108,.654]
-.660 .517 [.208,1.286]
-.391 .677 [.395,1.160]
-.567 .567
[.356,.905]
-3.435
[-5.921,-.949]
1846

.000 1.000 [1.000,1.000]
-.458 .633 [.186,2.153] .455
-1.684 .186 [.021,1.637] .126
-.228 .796 [.197,3.223] .744
-.404 .668 [.209,2.132] .487
-4.343
[-9.564,.878]
684

.000 1.000 [1.000,1.000]
-2.243 .106
[.037,.302]
-.493 .611 [.202,1.843]
-.453 .636 [.356,1.137]
-.714 .490
[.332,.723]
-3.149
[-5.254,-1.043]
1019

OR

95% CI

p

.737 [.211,2.571] .625
.692 [.293,1.638] .394
1.006 [1.000,1.012] .060
.005
.152
.151
.019
-

a – gender is constant in male and female only models; b – interactions between Toxoplasma and gender could not be estimated for PD or GAD
because there were no male subjects with latent toxoplasmosis and either disorder; c – 95% confidence interval reported is for β; d – Toxoplasma is
constant in male only models for PD or GAD because there were no male subjects with latent toxoplasmosis and either disorder; source: NHANES
1999–2000, 2001–2002, and 2003–2004.

than high school (25.9%), high school (16.1%), and more
than high school (9.4%), (X2(2) = 47.708, p < 0.0001).
Seroprevalence by ethnicity was highest in those identifying themselves as Mexican Americans (23.2%). The NonHispanic white group had the lowest prevalence at 10.3%,
and the Non-Hispanic black group had a prevalence of
16.7%. The overall difference in prevalence between the
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three groups was statistically significant (X2(2) = 21.760,
p < 0.0001).
Approximately 7% of the sample met CIDI criteria for
MDD, 2% for GAD and 2% for PD. Mexican Americans
were significantly less likely than non-Hispanic whites
to have MDD (OR = 0.551, 95% CI = 0.327–0.930) but
not PD (OR = 0.425, 95% CI = 0.174–1.039) or GAD
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(OR = 0.517, 95% = 0.208–1.286). Males displayed
a consistently lower prevalence among the three disorders, although the relationship was not statistically significant. Age was positively associated with depression
(OR = 1.003, 95% CI = 1.000–1.007), although the age
range of the entire sample was only from 20 to 39 years.
Higher values of PIR were associated with fewer cases of
both PD (OR = 0.595, 95% CI = 0.448–0.791) and GAD
(OR = 0.567, 95% CI = 0.356–0.905). Our results using
presence or absence of latent toxoplasmosis showed no
significant association in the fully adjusted model with covariates between T. gondii IgG seroprevalence and MDD
(OR = 0.484, 95% CI = 0.181–1.290), PD (OR = 0.683,
95% CI = 0.199–2.343) or GAD (OR = 0.737, 95%
CI = 0.211–2.571) (Table 3). We also estimated models
that included interactions between T. gondii and gender
but do not report them because the interactions were nonsignificant.
A logistic regression model with anti-toxoplasmosis
IgG antibody as a continuous variable was carried out separately for the latent toxoplasmosis positive and negative
groups to determine if there were differences in serointensity associated with MDD. It should be pointed out that the
NHANES database arbitrarily recorded all IgG antibody
values ≥ 240 as 240. Thus, the estimates of the relationship between serointensity reported here are likely conservative for the latent Toxoplasma-positive group as there
were many participants with values of 240. In this logistic
regression analysis, the IgG level was non-significantly
related to MDD in both the latent Toxoplasma-positive
(OR = 1.0351, 95% CI = 0.8570–1.2502, n = 1 813) and
negative group (OR = 1.0002, 95% CI = 0.9900–1.0105,
n = 290) when modelled without control variables. In
models controlling for gender, age, ethnic background,
educational attainment and PIR, IgG antibody levels were
again non-significant for the latent Toxoplasma-positive
(OR = 0.9971, 95% CI = 0.7906–1.2576, n = 1 562) and
negative groups (OR = 0.9996, 95% CI = 0.9876–1.0118,
n = 225).
We also estimated logistic regression models with
and without control variables for the relationship of anti-toxoplasmosis IgG antibodies serointensity with PD
and GAD for latent Toxoplasma-positive and negative
groups. Similar to the findings for MDD, the IgG levels
were not associated with PD among the latent Toxoplasma-negative group in a model without control variables
(OR = 0.9575, 95% CI = 0.6737–1.3608, n = 1 818) as
well as a model with control variables (OR = 0.9348,
95% CI = 0.6006–1.4550, n = 1565). On the other hand,
the relationship was statistically significant in the latent Toxoplasma-positive group (OR = 1.0223, 95%
CI = 1.0030–1.0420, n = 290). However, after adding
control variables, the relationship between IgG levels in PD was no longer significant (OR = 1.0366, 95%
CI = 0.9985–1.0760, n = 58). IgG levels were also not

associated with GAD among the latent Toxoplasma-negative group without control variables (OR = 0.9189, 95%
CI = 0.6649–1.2697, n = 1 818) or with control variables
(OR = 0.8171, 95% CI = 0.5067–1.3176, n = 1 565). Interestingly, models for PD and GAD were identical for the
latent Toxoplasma-positive group. This was because, in
every case, PD and GAD were comorbid. In other words,
among respondents in the latent toxoplasmosis positive
group, those who had PD also had GAD. Consequently,
the results for PD described above also characterised the
relationship between IgG levels and GAD.
Discussion
In contrast to studies that reported an association between latent toxoplasmosis and schizophrenia, bipolar
disorder and self-harm, we found no association using
presence or absence of latent toxoplasmosis as a binary
variable between latent toxoplasmosis and MDD, GAD
and PD adjusted for gender, ethnic origin, age, educational attainment and PIR in a sample representative of
the United States population. In the unadjusted model for
the latent Toxoplasma-positive group, there was an association of anti-Toxoplasma IgG antibodies with GAD and
PD, which was no longer apparent after adding the control variables, although the number of subjects dropped to
only 58 in the fully adjusted model. Any possible association of latent toxoplasmosis with GAD and PD requires
further study.
However, the overall lack of association we found between latent toxoplasmosis and GAD and PD is broadly
consistent with previous research in animal models showing decreased novelty avoidance (Webster 2007) and anxiolytic-like behaviour (Berdoy et al. 2000), findings suggesting that latent toxoplasmosis in rodents is associated
with an anxiolytic-like response. The lack of an association with GAD and PD is further consistent with previous
reports that latent toxoplasmosis in humans is associated
with a perception of decreased diplomacy (Flegr 2010)
and with decreased conscientiousness.
Further, the finding that Toxoplasma seroprevalence
is not associated with GAD or PD is consistent with the
report that women seropositive for toxoplasmosis were
not anxious in situations in which other women would be
(Flegr 2010). Latent toxoplasmosis in humans has been
associated with behaviour characterised by decreased inhibition, such as increased risk for self-harm (Pedersen
et al. 2012), whereas a characteristic of anxiety is increased inhibition. Our findings that latent toxoplasmosis
in humans is not associated with GAD or PD as such are
consistent with both animal models and human studies
that show decreased inhibition and increased impulsivity
(Webster 2007, Pedersen et al. 2012).
The lack of an association between latent toxoplasmosis and MDD that we found is similar to findings from
a study done in China reporting that patients with affec-
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tive disorder did not have elevated seroprevalence of toxoplasmosis compared to controls (Wang et al. 2006) and
with other previous studies (Cetinkaya et al. 2007, HinzeSelch et al. 2007, Hamidinejat et al. 2010, Pearce et al.
2012). In contrast to findings that high IgG anti-toxoplasmosis antibody levels were positively associated with
MDD (Hinze-Selch et al. 2007), we found no evidence
supporting an association between anti-Toxoplasma IgG
serointensity and MDD.
In the present study, we found an overall United States
prevalence of 15.8% for latent toxoplasmosis, which is
similar to, but somewhat lower than, the prevalence of
22.5% reported by Jones et al. (2001), though this may
have been due to methodological differences including
a much smaller sample size and smaller age range in the
present study. The prevalence did not differ significantly
between men and women, consistent with previous findings (Montoya and Liesenfeld 2004). However, there was
a significant difference in prevalence by ethnic groups
and by education level. We also found that approximately
7% of the sample met criteria for 12-month prevalence of
MDD and 2% for GAD and for PD. These prevalences for
MDD, GAD and PD are similar to those reported by Kessler et al. (2012) showing a 12-month prevalence among
people ages 18 to 64 years of MDD of 9.3%, of GAD of
2.9%, and of PD of 3.1%, suggesting that the estimates
obtained from the CIDI in the NHANES survey approximate the estimates obtained in epidemiological surveys.
The genetic and neural mechanisms associated with
latent toxoplasmosis and associated behavioural changes
reported in previous studies are unclear, although several
possibilities exist. In mice, latent toxoplasmosis is associated with increased dopamine, although not with changes
in serotonin (Stibbs 1985). Similarly, latent toxoplasmosis may increase dopamine metabolism (Prandovszky et
al. 2011). Finally, rats with latent toxoplasmosis treated
with a dopamine-2 antagonist decreased their risky behaviour (Webster et al. 2006), although the dopamine-2
antagonist haloperidol inhibits Toxoplasma growth in
vitro (Jones-Brando 2003) and thus may have affected the
animal behaviour not by antagonising dopamine but by
inhibiting the infection itself.
Another possible mechanism underlying the behavioural changes associated with latent toxoplasmosis in
previous studies has to do with the presence and distribution of parasitic cysts in the central nervous system. In
mice, Berenreiterová et al. (2011) found that while latent
toxoplasmosis cysts were distributed throughout the brain,
the highest densities were in the telencephalon, hippocampus and amygdala with relative sparing of the cerebellum, caudate and putamen. Thus, based on the animal
data, it would seem possible that parasitic cysts in these
regions in humans could alter both frontal and limbic areas, as well as frontolimbic connectivity, which could then
result in behavioural and emotional changes. Along these
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lines, prior work in humans has demonstrated an association between regional activity of the prefrontal cortex and
amygdala with anxiety disorders (Etkin and Wager 2007)
as well as decreased structural connectivity between these
same regions (Tromp et al. 2012). However, abnormalities in these regions, particularly after an acquired lesion,
have not always resulted in increased anxiety or depression. For example, decreases in emotional responsiveness
and anxiety have also been demonstrated (Bechara et al.
2000, Vasa et al. 2004). As such, our findings suggesting
no association between anti-T. gondii antibody seroprevalence and serointensity are consistent with the notion that
frontal dysfunction does not always result in depression
or anxiety.
In addition to neurotransmitter changes and cysticrelated structural changes in the brain (i.e. brain injury)
associated with latent toxoplasmosis in animal models,
there is also evidence for alterations in gene expression.
Xiao et al. (2012) demonstrated that female mice infected
with latent toxoplasmosis had altered gene expression
associated with forebrain development and neurogenesis. Thus, cortical regions might not only be injured by
the presence of cysts, but latent toxoplasmosis may alter
the development of these same regions, which may help
explain behaviours such as the locomotor hyperactivity
females demonstrate in open field-testing. Accordingly,
animal models suggest that latent toxoplasmosis has an
affinity for cortical and select subcortical regions related
to higher-order behaviour and impulse control as well as
to limbic regions and emotional tone and regulation. Furthermore, alterations in neurotransmitter levels and metabolism and even gene expression of both neurotransmitters and forebrain development may also be altered.
Berenreiterová et al. (2011) suggest that latent toxoplasmosis may cause neuronal degeneration in local brain
regions or produce an immune response that alters neurotransmitters, further mechanisms that could be associated with the behavioural changes associated with latent
toxoplasmosis. Latent toxoplasmosis is associated with
an immune response (Carruthers and Suzuki 2007) that
could also alter brain function. In addition, host factors
are likely important in determining susceptibility to toxoplasmosis (Carruthers and Suzuki 2007). In fact, in their
study of toxoplasmosis cyst distribution in mice, Berenreiterová et al. (2011) found large interindividual variation
in parasite load, indicating that individual host factors affect the parasite dose in an individual brain.
Strengths of the present study include the use of
a large community sample with data combined over three
NHANES surveys, in which we corroborate the findings
of Pearce et al. (2012) suggesting that there is no association between seroprevalence of latent toxoplasmosis and
MDD. The findings also provide limited support suggesting that anti-T. gondii antibody serointensity may be positively associated with GAD and PD. We also controlled
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for ethnic background, gender, socioeconomic status and
education level. Further, to our knowledge this is the first
study that has systematically evaluated the association between latent toxoplasmosis and PD and GAD.
Several limitations require consideration when interpreting our findings. The present study carries with it all
the limitations associated with a cross-sectional design.
Similarly, we simply used IgG antibody titre against
T. gondii to determine seroprevalence of latent infection
with toxoplasmosis and could not determine when the infection originally occurred. It is possible that length of
time with a chronic infection may influence the risk of
developing MDD, GAD or PD, or perhaps even symptom severity. Further, the diagnosis of major depressive
disorder, generalised anxiety disorder and panic disorder
relied exclusively on a computer-based structured interview completed by the subjects. There was no other
diagnostic process such as a clinical interview by which
to corroborate the questionnaire findings. Also, the CIDI
was used to address the presence of these diagnoses in the
past 12 months only. Since the NHANES dataset was not
designed explicitly to evaluate the association between
latent toxoplasmosis and MDD, GAD and PD, we were
unable to use outcome data designed specifically for the
question we investigated. While we attempted to adjust
for ethnic background, age, gender, education and PIR
as a proxy for socioeconomic status, other variables for

which we did not control could have resulted in residual
confounding. Finally, these particular NHANES data sets
only allowed for inclusion of subjects whose ages were
between 20 and 39 years. It is possible that subjects with
a longer duration of Toxoplasma seropositivity could
have had more depression and anxiety or perhaps risk of
developing depression or anxiety may be linked to age
at the time of initial acute infection. These specific possibilities could not be investigated in these cross-sectional
NHANES data sets.
Although latent toxoplasmosis in humans has been associated with a variety of behavioural changes including
self-inflicted aggression, bipolar disorder and schizophrenia, we found no evidence that it is associated with MDD
within the context of the limitations of this study. More
detailed assessment of mood state and affective regulation, however, could show evidence that latent toxoplasmosis affects mood. Further, we found that seroprevalence of latent toxoplasmosis was not associated with
GAD or PD, although there was limited evidence of an
association of IgG serointensity with GAD and PD, a possibility that requires further investigation. Given the high
global prevalence of latent toxoplasmosis and evidence
that it affects human behaviour and neuropsychological
function, additional research into the neuropsychiatric
and neuropsychological effects of latent toxoplasmosis is
needed.
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